In the United States:
Locations: Swiftwater, PA
Revenue: $2.512 billion in 2008 in the U.S.
More than 3,200 employees
A global company:
Headquarters: Lyon, France
Revenue: €3,483million in 2009 (+19.2% compared to 2008 at constant exchange rates)
More than 12,500 employees worldwide
More than 50% of staff devoted to industrial operations
11 production and/or R&D sites located in Marcy l'Etoile and Val de Reuil, France; in
Swiftwater (Pennsylvania), Cambridge and Canton (Massachusetts), and Rockville
(Maryland), USA; in Toronto, Canada; in Pilar, Argentina; in Shenzhen, China; in
Hyderabad, India and in Chachoengsao, Thailand.
3 New facilities under construction in Ocoyoacac, Mexico; Neuville, France; and
Shenzhen, China.
Investment in research and production capacity:
More than 1.6 billion doses of vaccines produced yearly to immunize more than 500
million people in the world
Largest product range available, against 20 infectious diseases
More than €1 million euros invested every day in R&D
Nearly €1.6 billion euros invested in the last 5 years in production capacity